Nimesulide linked acyl thioureas potent carbonic anhydrase I, II and α-glucosidase inhibitors: Design, synthesis and molecular docking studies

dc.contributor.authorAhmed, Atteeque
dc.contributor.authorSha, Imran
dc.contributor.authorSaeed, Aamer
dc.contributor.authorShabir, Ghulam
dc.contributor.authorSaleem, Arslan
dc.contributor.authorTaslimi, Parham
dc.contributor.authorTok, Tugba Taskin
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T09:58:59Z
dc.date.created2022
dc.date.issued2022
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractMolecular hybridization has emerged as an interesting strategy to improve the effectiveness and the scope of well-known drugs. Nimesulide has been used as non-steroidal anti-inflammatory (NSAID) drug for decades and marketed as NIMS (TM). Nimesulide (3) possesses a nitro group which shows toxic behavior. To enhance the scope and efficacy of the drug nitro group was reduced to amino group (4) and reacted with isothiocyanates of different substituted acid chlorides to afford Nimesulide-acyl thiourea conjugates (5a-n). In the present research work 14 derivatives were synthesized and tested for carbonic anhydrase I, II and alpha-glucosidase Inhibition assay. These findings established that all new derivatives are more effective alpha-amylase inhibitors than Acarbose (IC50: 10000 nM) used as a positive control alpha-amylase inhibitor. Among the tested compounds 5g, 5l and 5m were determined to be the best hCA I, II inhibitors.
dc.description.sponsorshipHigher Education Commission of Pakistan [NRPU-I/10579]
dc.description.sponsorshipThe authors gratefully acknowledge the research grant from Higher Education Commission of Pakistan under the project No. NRPU-I/10579. The authors also thank Esin Ak & imath; Yalcin and the research group for technical assistance.
dc.identifier.doi10.1016/j.ejmcr.2022.100082
dc.identifier.issn2772-4174
dc.identifier.orcidAHMED, Dr. ATTEEQUE/0000-0002-4022-4282
dc.identifier.orcidUc, Eda Mehtap/0000-0002-9259-5704
dc.identifier.orcidshafique, imran/0000-0002-7172-0991
dc.identifier.orcidTASKIN-TOK, Tugba/0000-0002-0064-8400;
dc.identifier.scopus2-s2.0-85148461698
dc.identifier.scopusqualityQ4
dc.identifier.urihttps://doi.org/10.1016/j.ejmcr.2022.100082
dc.identifier.urihttps://hdl.handle.net/11772/19969
dc.identifier.volume6
dc.identifier.wosWOS:001097149200005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Journal of Medicinal Chemistry Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzWoS_20251016
dc.subjectNimesulide Analogues
dc.subjectAcyl Thiourea
dc.subjectMolecular Hybridization
dc.subjectSynthetic Approaches
dc.subjectHca I, Ii
dc.subjectAlpha-Amylase Inhibitor
dc.titleNimesulide linked acyl thioureas potent carbonic anhydrase I, II and α-glucosidase inhibitors: Design, synthesis and molecular docking studies
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar